Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis-Reference-Cited by-同舟云学术

Sustained virological response to direct-acting antiviral regimens reduces the risk of hepatocellular carcinoma in HIV/HCV-coinfected patients with cirrhosis

Published:2018-07-02 Issue:9 Volume:73 Page:2435-2443
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Merchante Nicolás¹^ORCID,Rivero-Juárez Antonio²,Téllez Francisco³,Merino Dolores⁴,Ríos-Villegas María J⁵,Villalobos Marina⁶,Omar Mohamed⁷,Rincón Pilar¹,Rivero Antonio²,Pérez-Pérez Montserrat⁸,Raffo Miguel⁴,López-Montesinos Inmaculada⁵,Palacios Rosario⁶,Gómez-Vidal María A⁷,Macías Juan¹,Pineda Juan A¹,Merchante Nicolás,Rincón Pilar,Iglesias María,Real Luis M,Macías Juan,Pineda Juan A,Juárez Antonio Rivero,Brieva Teresa,Espejo Angela Camacho,Rivero Antonio,Téllez Francisco,Merino Dolores,Raffo Miguel,Ríos Villegas María J,Montesinos Inmaculada López,Villalobos Marina,Palacios Rosario,Santos Jesús,Omar Mohamed,Gómez Vidal Maria A,Pérez Monserrat Pérez,

Affiliation:

1. Unidad Clínica de Enfermedades Infecciosas y Microbiología, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario de Valme, Sevilla, Spain

2. Unidad de Enfermedades Infecciosas, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Universidad de Córdoba (UCO), Córdoba, Spain

3. Unidad de Enfermedades Infecciosas, Hospital Universitario de Puerto Real, Cádiz, Spain

4. Unidad de Gestión Clínica de Enfermedades Infecciosas, Hospitales Juan Ramón Jiménez e Infanta Elena, Huelva, Spain

5. Unidad de Enfermedades Infecciosas, Hospital Universitario Virgen Macarena, Sevilla, Spain

6. Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Instituto de Biomedicina de Málaga (IBIMA), Hospital Virgen de la Victoria, Málaga, Spain

7. Unidad de Enfermedades Infecciosas, Complejo Hospitalario de Jaén, Jaén, Spain

8. Unidad de Gestión Clínica de Enfermedades Infecciosas y Microbiología, Hospital de La Línea de la Concepción, AGS Campo de Gibraltar, Cádiz, Spain

Funder

Consejería de Salud de la Junta de Andalucía

Servicio Andaluz de Salud

Fondo de Investigaciones Sanitarias ISCIII

Instituto de Salud Carlos III

Spanish AIDS Research Network

Plan Nacional R + D+I

Fondo Europeo de Desarrollo Regional

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/9/2435/25523299/dky234.pdf

Reference49 articles.

1. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015;Akinyemiju;JAMA Oncol,2017

2. Hepatocellular carcinoma;Forner;Lancet,2012

3. Hepatocellular carcinoma in cirrhosis: incidence and risk factors;Fattovich;Gastroenterology,2004

4. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients;Sangiovanni;Hepatology,2006

5. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease;Lok;Gastroenterology,2009

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection;Alimentary Pharmacology & Therapeutics;2023-07-28

2. Fibrosis Stage-specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-acting Antivirals: A Systematic Review and Meta-analysis;Clinical Gastroenterology and Hepatology;2022-05

3. Cancer Microbiology;JNCI: Journal of the National Cancer Institute;2021-11-24

4. A Genome-Wide Association Study on Liver Stiffness Changes during Hepatitis C Virus Infection Cure;Diagnostics;2021-08-20

5. Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome;Scientific Reports;2021-07-15